Identifying new pathway of EZH2 gene may lead to targeted therapies for aggressive br

[News]

Scientists from A*STAR's Genome Institute of Singapore and the Cancer Science Institute of Singapore at the National University of Singapore came together to understand how EZH2, a cancer-promoting gene which is known to be involved in many types of cancers, is activated in breast cancer and lymphomas.

More... (http://www.news-medical.net/news/20160719/Identifying-new-pathway-of-EZH2-gene-may-lead-to-targeted-therapies-for-aggressive-breast-cancer.aspx)